FROM OUR BLOG

Iran Blockade Roils Oil Markets; Pearl Health Raises $110M

Trump reinstates Iran naval blockade, lifting oil prices; Pearl Health banks $110M for AI Medicare tools. Plus bank earnings and chipmaker selloff.

July 13, 2026

Healthcare Practice & Business Deals

TEDMED 2013 Review
Photo: juhansonin — BY 2.0

This week’s healthcare deal flow skews toward venture financing rather than practice-level M&A, with one notable funding round standing out from the broader digital-health rebound.

Pearl Health raises $110M for AI-driven Medicare platform. Health tech startup Pearl Health secured $110 million in a mix of debt and equity financing to expand its artificial intelligence platform serving Medicare providers. The company plans to deploy the capital toward AI agents designed to handle administrative tasks and broader technology buildout for primary care practices operating in value-based arrangements. The round places Pearl Health among the larger independent raises in the Medicare enablement space this cycle.

Digital health VC hits $7.4B in first-half 2026. While not a single practice transaction, the macro funding environment shaping practice valuations bears noting: digital health companies attracted $7.4 billion in venture capital during the first half of 2026, with 19 companies completing 20 “megadeals” of $100 million or more — representing 45% of all capital deployed. Analysts caution that smaller startups and independent practices remain largely outside this capital wave, echoing a pattern seen in broader biotech funding where the gap between large and small recipients is widening.

No qualifying small-to-medium practice acquisitions — such as DSO roll-ups, independent clinic sales, or group-practice transactions — appeared in this week’s candidate pool. Readers tracking specific deal flow in dental, veterinary, behavioral health, or physical therapy should monitor trade sources directly for emerging transactions.

Global Markets & Macro

Graph With Stacks Of Coins
Photo: kenteegardin — BY-SA 2.0

Geopolitical risk dominated market action to open the week, with Middle East escalation driving oil higher and pushing equities into risk-off territory alongside a busy bank earnings calendar.

Trump reinstates Iran naval blockade; oil surges. President Trump announced the reinstatement of a U.S. blockade on Iranian ships transiting the Strait of Hormuz and declared that a 20% fee would be charged on all other cargo moving through the waterway, with the U.S. positioning itself as the “guardian” of the route. Oil prices rallied sharply on the news, dashing near-term hopes for a recovery in global shipping flows through the strait. Iran’s state-affiliated media quoted officials claiming Iran retains control of the passage and would escalate its response. Separately, Dubai announced plans to develop a new port on the UAE’s east coast to provide an alternative route bypassing the Strait of Hormuz entirely — a significant infrastructure shift reflecting how seriously regional players are treating the disruption risk.

U.S. and European equities sell off on risk-off sentiment. U.S. stocks fell Monday as investors digested the Hormuz escalation alongside a broader move away from risk assets. Wall Street tech shares dropped after Asian chipmakers — including TSMC, SK Hynix, and Samsung Electronics, which together account for roughly 29% of the MSCI Emerging Markets index — were hammered in Asian trading. European stocks were broadly muted, with energy sector gains offsetting losses in technology and travel shares lifted by higher oil prices.

Major bank earnings in focus. Wall Street’s largest institutions begin reporting this week against a backdrop of elevated expectations. Analysts highlight capital markets activity as a key tailwind, while deposit costs and credit quality are identified as the primary downside risks to watch. Goldman Sachs faces the highest bar for demonstrating earnings strength, while succession questions are expected to draw investor attention at JPMorgan Chase. Morgan Stanley has been flagged as a standout pick by at least one analyst, despite rich valuations across the sector.

Dollar vulnerable if AI stock selloff deepens. Apollo Global Management’s chief economist Torsten Slok warned that the dollar’s recent gains are exposed if the selloff in artificial intelligence stocks accelerates. The caution lands as commentary across financial media is increasingly focused on the concentration of capital in a narrow set of AI-related names — a theme that, combined with private credit stress signals, is drawing growing scrutiny from market watchers.

Ukraine intensifies drone campaign against Russia. Ukraine’s deep-strike drone operations against Russian territory have intensified, with Kyiv targeting Russian refineries in a campaign that has sparked a domestic fuel crisis inside Russia. The escalation adds another layer of geopolitical uncertainty to global energy markets already strained by the Hormuz situation.

What to Watch

The week ahead sits at the intersection of geopolitical risk and corporate earnings season. How quickly — if at all — U.S.-Iran tensions ease will determine whether oil’s rally holds and whether global shipping costs feed into a fresh round of inflationary pressure, a dynamic that complicates the Federal Reserve’s rate path just as markets are hoping for relief. For healthcare practice owners and advisors, rising rate uncertainty and tightening credit conditions remain the central variables in deal financing; the concentration of new capital in large-platform AI deals, rather than small-to-medium practice acquisitions, underscores the importance of timing and positioning for sellers entering the market in the second half of 2026.

THINKING ABOUT SELLING YOUR MEDICAL PRACTICE?

Get a confidential practice valuation.

If you’re considering selling your practice — or exploring your options — a confidential valuation is a helpful first step. Understanding market conditions and potential value provides clarity and supports better decisions around timing and strategy.

START THE CONVERSATION

If you’re considering a sale, exploring acquisitions or planning ahead,
we’re here to help.

Schedule a confidential consultation to learn how our services can support your goals.